View Older Stories View More Recent Stories
-
GreenCarNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Forecasts $75M in GAAP Revenue Over Next 6 Months, Implements Immediate Measures to Cut Overall Expenses
-
InvestorWire is the Official NewsWire of Quant Strats London
-
Territorial Bancorp (TBNK) Urges Shareholders to Vote FOR Hope Bancorp Merger (HOPE)
-
Territorial Bancorp Urges Shareholders to Vote FOR Hope Bancorp Merger
-
Mullen Automotive (MULN) Cuts 20% Staff, Guides $75M in GAAP Revenue for Next 6 Months, Announces Other Expense Reduction
-
Mullen Announces Strong Forecast of $75M in GAAP Revenue for Next 6 Months and Immediate Reduction of $5.5M in Monthly Operating Expenses
-
Canada's Ivey PMI shows activity expanding in September
-
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024
-
European shares close up as bumper US jobs data quashes growth worries
-
US port strike ends, leaving cargo backlog
-
Canada's services PMI hits six-month low in September
-
Exxon's deal with unions at Port Jerome refinery to allow job-cutting plan to move ahead
-
US planned layoffs dip in September, recruitment firm Challenger says
-
MCT Reports 3% Increase in Mortgage Lock Volume, Refinance Activity Buoys Market
-
US port workers and operators reach deal to end East Coast strike immediately
-
Dollar hits six-week high before payrolls report
-
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1
-
Construction sector helps to lift US private payrolls in September
-
Verrica Pharmaceuticals (VRCA) Announces Restructuring of Commercial Organization
-
Verrica Pharmaceuticals Announces Restructuring of Commercial Organization
-
Philippine outsourcing to grow 7% this year despite AI threat, industry group says
-
Canaccord Genuity Maintains Beachbody Company (BODI) at Buy on job cuts
-
S.Korea factory activity shrinks sharply as overseas demand weakens, PMI shows
-
Peloton beats shareholder lawsuit over post-pandemic financial forecasts
-
OVER ONE DOZEN GUARANTEED INCOME STUDIES SHOW INCREASED EMPLOYMENT, BETTER FINANCIAL STABILITY AND OTHER KEY BENEFITS
-
CVS Health to lay off nearly 2,900 employees in cost-cutting push
-
Exclusive-Sonos CEO promises reforms after May app release 'failure'; leaders to forgo bonuses
-
Zero Layoffs in 99 Years: Torani Redefines What It Means to be a “People-First Company” as it Surpasses $500 Million in Annual Revenue
-
Casino Group continues its transformation
-
Titanic builder Harland & Wolff appoints administrators, to cut jobs
-
Car parts supplier Forvia cuts 2024 outlook again, to speed up job cuts
-
Latest inflation data could boost case for more big Fed rate cuts
-
German unemployment rises more than expected in September, labour office says
-
Nano One Materials Corp (NANO:CN) PT Raised to Cdn$1 at TD Cowen
-
Apple supplier Jabil announces restructuring, beats fourth-quarter estimates
-
Six ECB governors say they support UniCredit-Commerzbank deal in principle
-
Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
-
UniCredit overtures hold few fears for Germany's Mittelstand
-
Volkswagen digs in as workers threaten strikes over plant closures
-
Fulcrum Therapeutics Inc. (FULC) will reduce its workforce
-
Analysis-Germany talks tough but has limited room to halt UniCredit's advance on Commerzbank
-
Paramount Global begins second phase of layoffs in U.S., internal memo says
-
Exclusive-RBC bankers fear layoffs as pledge to keep HSBC staff nears end, sources say
-
Australia's central bank holds rates, softens hawkish stance slightly
-
Citi says the Fed will deliver another 50bp cut in November
-
OMTech Polar+: Revolutionizing Desktop Laser Engraving with the All-in-one Touchscreen and Higher Power
-
Tempur Sealy to divest more than 100 stores in bid to close $4 billion Mattress Firm deal
-
Cidara Therapeutics (CDTX) Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
-
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
-
Volkswagen CEO expects significant concessions from unions in crunch talks
